Combined Therapy in Age-Related Macular Degeneration (ARMD)

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Age-Related Macular Degeneration
Interventions
PROCEDURE

Low fluorescence Photodynamic therapy

42 J/cm2 for 72 sec

PROCEDURE

core pars plana vitrectomy

24 hours after photodynamic therapy, 1.5 mL core pars plana vitrectomy

DRUG

dexamethasone

intravitreal injection of 0.8 mg dexamethasone

DRUG

bevacizumab

intravitreal injection of 1.25 mg bevacizumab

PROCEDURE

core pars plana vitrectomy

0.4 mL core pars plana vitrectomy

DRUG

triamcincolone

intravitreal injection of 8 mg triamcincolone

Trial Locations (1)

60590

Abteilung für Netzhaut und Glaskörperchirurgie, Frankfurt am Main

All Listed Sponsors
lead

Johann Wolfgang Goethe University Hospital

OTHER

NCT00805649 - Combined Therapy in Age-Related Macular Degeneration (ARMD) | Biotech Hunter | Biotech Hunter